Abbott Top Management Team Brings Device/Diagnostic Background
This article was originally published in The Gray Sheet
Executive Summary
Abbott's corporate image as a device and diagnostics company will be enhanced with the selection of its new top management team, announced Sept. 15.
You may also be interested in...
“Realistic” CEO Parkinson Will Lead Baxter Through Continued Restructuring
Baxter's decision to tap former Abbott exec Robert Parkinson as chairman and CEO sets the stage for swift operational reforms at the highly diversified firm
“Realistic” CEO Parkinson Will Lead Baxter Through Continued Restructuring
Baxter's decision to tap former Abbott exec Robert Parkinson as chairman and CEO sets the stage for swift operational reforms at the highly diversified firm
Abbott Sews Up Puncture Seal Deal As Perclose Stock Falls On Recall Rumors
Abbott's July 8 acquisition of Perclose in a stock swap valued at about $680 mil. portends the firm's long-term strategy to expand its interventional cardiology presence at a tempered pace.